Recent studies by Wei et al., have demonstrated that miR-218 regulated the biological process of melanoma development by targeting the 3'-UTR of the oncogenes CIP2A and BMI1 and thus observed that CIP2A and BMI1 knockdown phenocopies miR-218 overexpression [76]. This evidence concerns the gene BMI1 and melanoma.